Suchergebnisse - (Subject:"ritonavir")

PubPharm (763)

1

A global phase II randomized trial comparing oral taxane ModraDoc006/r to intravenous docetaxel in metastatic castration resistant prostate cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Vaishampayan, U. | Keessen, M. | Dreicer, R. | +11

2

Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19

enthalten in: The New England journal of medicine | 2024

von Hammond, J. | Fountaine, R. | Yunis, C. | +10

3

COVID-19 Rebound After VV116 vs Nirmatrelvir-Ritonavir Treatment : A Randomized Clinical Trial

enthalten in: JAMA network open | 2024

von Yang, Z. | Xu, Y. | Zheng, R. | +28

4

Safety and efficacy of doravirine as first-line therapy in adults with HIV-1 : week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials

enthalten in: The lancet. HIV | 2024

von Orkin, C. | Molina, J. | Cahn, P. | +112

5

A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance

enthalten in: The Journal of antimicrobial chemotherapy | 2024

von Abdullahi, A. | Diaz, A. | Fopoussi, O. | +5

6

Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19

enthalten in: The New England journal of medicine | 2024

von Cao, B. | Wang, Y. | Lu, H. | +28

CommentIn: N Engl J Med. 2024 Apr 25;390(16):1533-1534. - PMID 38657253

7

Phase I study, and dosing regimen selection for a pivotal COVID-19 trial of GST-HG171

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Zhang, H. | Zhou, J. | Chen, H. | +10

8

Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV) : an open-label, phase 2, randomised, controlled, adaptive trial

enthalten in: The Lancet. Infectious diseases | 2024

von Schilling, W. | Jittamala, P. | Watson, J. | +89

ErratumIn: Lancet Infect Dis. 2023 Dec;23(12):e511. - PMID 37839427

9

Nirmatrelvir/ritonavir use in pregnant women with SARS-CoV-2 Omicron infection : a target trial emulation

enthalten in: Nature medicine | 2024

von Wong, C. | Lau, K. | Chung, M. | +6

10

Efficacy and safety of Huashi Baidu granule plus Nirmatrelvir-Ritonavir combination therapy in patients with high-risk factors infected with Omicron (B.1.1.529) : A multi-arm single-center, open-label, randomized controlled trial

enthalten in: Phytomedicine : international journal of phytotherapy and phytopharmacology | 2023

von Yu, Z. | Zheng, Y. | Chen, B. | +15

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[77]